Ocugen

OCGN51

Penny Stock

$0.93arrow_drop_down0.90%-$0.00

Penny Stock

OCGN51

$0.93

arrow_drop_down0.90%-$0.00

Penny Stock

Performance History

Key Stats
Open	$0.93
Prev. Close	$0.93
EPS	-0.18
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$272.63M
PE Ratio	-

	LOW	HIGH
Day Range	0.92	0.95
52 Week Range	0.34	2.10

Ratios







EPS	-0.18

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Ocugen (OCGN)

Ocugen Inc (OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies to treat rare and underserved eye diseases. The company's primary product candidate is OCU400, a gene therapy product for the treatment of inherited retinal diseases. OCU400 has shown promising results in preclinical studies and is expected to enter clinical trials in the near future. Ocugen also has a collaboration agreement with Bharat Biotech to develop and commercialize a COVID-19 vaccine candidate, COVAXIN, in the United States. The company has exclusive rights to the vaccine candidate in the US market.

In terms of its stock price history, Ocugen has experienced significant volatility. The stock had a 52-week high of $18.77 and a 52-week low of $0.17. As of the latest trading session, the stock is trading in a day range of $1.20 to $1.40. The trading volume for Ocugen's stock has also been relatively high, indicating strong investor interest in the company. Despite the volatility, Ocugen has managed to maintain a market cap of around $500 million, reflecting investor confidence in its potential.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Shankar Musunuri M.B.A., MBA, Ph.D.
Headquarters: Malvern
Employees: 84
Exchange: NASDAQ

Keep an eye on Ocugen

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Ocugen 's (OCGN) price per share?

The current price per share for Ocugen (OCGN) is $0.93. The stock has seen a price change of -$0.01 recently, indicating a -0.91% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Ocugen (OCGN)?

For Ocugen (OCGN), the 52-week high is $2.1, which is 126.32% from the current price. The 52-week low is $0.34, the current price is 169.59% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Ocugen (OCGN) a growth stock?

Ocugen (OCGN) has shown an average price growth of -1.93% over the past three years. It has received a score of 31 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Ocugen as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Ocugen (OCGN) stock price performance year to date (YTD)?

As of the latest data, Ocugen (OCGN) has a year-to-date price change of 41.44%. Over the past month, the stock has experienced a price change of -16.96%. Over the last three months, the change has been -49.17%. Over the past six months, the figure is -35.41%. Looking at a longer horizon, the five-year price change stands at -48.9%.

help

Is Ocugen (OCGN) a profitable company?

Ocugen (OCGN) has a net income of -$63.08M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 88.34% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.35K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $6.04M, although specific revenue growth data is currently not available. The gross profit is $5.33M. Operating income is noted at -$65.53M. Furthermore, the EBITDA is -$50.51M.

help

What is the market capitalization of Ocugen (OCGN)?

Ocugen (OCGN) has a market capitalization of $272.63M. The average daily trading volume is 0.94, indicating the stock's liquidity and investor engagement.

News

Jun 24, 2024

Is Ocugen (OCGN) Stock Outpacing Its Medical Peers This Year?

Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease

HEALTH

CLINICAL STUDY

Jun 21, 2024

Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease

Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400—First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication

CLINICAL STUDY

Jun 20, 2024

Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400—First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication